Your browser doesn't support javascript.
loading
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.
Pressiat, Claire; Hirt, Déborah; Treluyer, Jean-Marc; Zheng, Yi; Morlat, Philippe; Naqvi, Alice; Tran, Laurent; Viard, Jean-Paul; Avettand-Fenoel, Véronique; Rouzioux, Christine; Meyer, Laurence; Cheret, Antoine.
Afiliação
  • Pressiat C; Paris Descartes University, EA 7323, Paris, France.
  • Hirt D; Clinical Pharmacology Department, AP-HP Paris Centre Hospital Group, Paris, France.
  • Treluyer JM; Paris Descartes University, EA 7323, Paris, France.
  • Zheng Y; Clinical Pharmacology Department, AP-HP Paris Centre Hospital Group, Paris, France.
  • Morlat P; Paris Descartes University, EA 7323, Paris, France.
  • Naqvi A; Clinical Pharmacology Department, AP-HP Paris Centre Hospital Group, Paris, France.
  • Tran L; Paris Descartes University, EA 7323, Paris, France.
  • Viard JP; Clinical Pharmacology Department, AP-HP Paris Centre Hospital Group, Paris, France.
  • Avettand-Fenoel V; Department of Internal Medicine and Infectious Diseases, Saint-André Hospital, CHU de Bordeaux, Bordeaux, France.
  • Rouzioux C; Infectious Diseases Unit, Nice Hospital, Nice, France.
  • Meyer L; University Paris Sud Inserm CESP U1018 AP-HP Hôpital de Bicêtre Epidemiology Department Le Kremlin-Bicêtre, Le Kremlin-Bicêtre, France.
  • Cheret A; Diagnostic and Therapeutic Center, Hôtel-Dieu, AP-HP, Paris, France.
J Antimicrob Chemother ; 73(4): 1020-1024, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29365125
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Fármacos Anti-HIV / Darunavir / Raltegravir Potássico / Maraviroc Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasma / Fármacos Anti-HIV / Darunavir / Raltegravir Potássico / Maraviroc Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França